Tfo Tdc, LLC Vertex Pharmaceuticals Inc Transaction History

Tfo Tdc, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $1.28 Million - $1.4 Million	-3,132 Reduced 99.94%	2 $0
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $1.07 Million - $1.28 Million	3,127 Added 44671.43%	3,134 $1.28 Million
Q3 2023 Nov 02, 2023	BUY	$338.18 - $362.46 $1,690 - $1,812	5 Added 250.0%	7 $2,000
Q1 2023 May 03, 2023	BUY	$283.23 - $323.1 $283 - $323	1 Added 100.0%	2 $0
Q4 2022 Feb 03, 2023	BUY	$285.76 - $321.48 $285 - $321	1 New	1 $0
Q2 2022 Jul 18, 2022	BUY	$234.96 - $292.55 $4,464 - $5,558	19 New	19 $5,000

1,718

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $108B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.